Form 4: Hagerty Director Sells $229K in Stock

Hagerty, Inc. Director Robert I. Kauffman, through Aldel LLC, sold over 21,000 shares of Class A Common Stock totaling approximately $229,000 under a pre-arranged 10b5-1 trading plan.

Summary

• Robert I. Kauffman, a Director of Hagerty, Inc. (HGTY), executed sales of Class A Common Stock through Aldel LLC.
• The sales were conducted pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2024.
• On August 21, 2025, 7,356 shares were sold at a weighted average price of $10.77 per share.
• On August 22, 2025, 6,081 shares were sold at a weighted average price of $10.92 per share.
• On August 25, 2025, 7,668 shares were sold at a weighted average price of $10.87 per share.
• Following these transactions, Aldel LLC beneficially owns 1,482,307 shares of Class A Common Stock.
• The total value of shares sold across these three dates is approximately $228,979.40.

Sentiment

Score: 5

Explanation: The sale of shares by a director is generally a neutral to slightly negative signal. However, the execution under a pre-arranged 10b5-1 plan mitigates the negative perception, suggesting it's for personal financial planning rather than a reaction to adverse company-specific news.

Positives

• The sales were executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled and non-discretionary transaction, which mitigates concerns about opportunistic insider selling.

Negatives

• A director of the company sold a significant number of shares, which can sometimes be perceived negatively by investors as it reduces insider ownership.

Risks

• Investor perception of insider selling, even if pre-planned, could lead to short-term negative sentiment regarding the company's prospects.

Related Party Transactions

• The transactions were conducted by Aldel LLC, an entity managed by the reporting person, Robert I. Kauffman, who has voting and investment discretion over its securities. This constitutes a related party transaction.

Stakeholder Impact

• Shareholders may view the reduction in insider ownership with slight concern, though the pre-planned nature of the 10b5-1 plan lessens the potential negative impact.
• Employees, customers, suppliers, and creditors are unlikely to be directly impacted by this insider transaction.

Key Dates

Recommendation

The Form 4 filing details a pre-planned sale of shares by a director, which is a routine event under a 10b5-1 trading plan. While insider selling can sometimes be a negative signal, the pre-scheduled nature suggests it is for personal financial management rather than a reflection of new, negative company-specific information. Therefore, this filing alone does not warrant a change in investment thesis, and a 'hold' recommendation is appropriate, pending further fundamental analysis of Hagerty, Inc.

Keywords

Hagerty, HGTY, Insider Sale, Form 4, Robert I Kauffman, Aldel LLC, Stock Transaction, Director, 10b5-1 Plan